Hartford Financial Management Inc. - CELLDEX THERAPEUTICS INC NEW ownership

Back to all holdings Add to watchlist

CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 132 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.

Links
Filings
External links
Quarter-by-quarter ownership
Hartford Financial Management Inc. ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2023$496
-18.8%
180.0%0.00%–
Q2 2023$611
-5.7%
180.0%0.00%–
Q1 2023$648
-19.2%
180.0%0.00%–
Q4 2022$802
-19.8%
180.0%0.00%–
Q3 2022$1,0000.0%180.0%0.00%–
Q1 2022$1,0000.0%180.0%0.00%–
Q4 2021$1,0000.0%180.0%0.00%–
Q3 2021$1,0000.0%180.0%0.00%–
Q2 2021$1,000–18–0.00%–
 Download
Other shareholders

There were no reported owners of CELLDEX THERAPEUTICS INC NEW in Q2 2021.

NameSharesValueWeighting ↓
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders